HER2-targeted immunoconjugates for breast cancer: Ancestry and dose adjustment for thrombocytopenia.
Year: 2022
Type: conference-abstract
Source: Journal of Clinical Oncology
Language: English
Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4281785630
